Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Return on Sales (2016 - 2025)

Historic Return on Sales for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to 0.07%.

  • Nephros' Return on Sales rose 200.0% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year increase of 1500.0%. This contributed to the annual value of 0.01% for FY2024, which is 1200.0% up from last year.
  • According to the latest figures from Q3 2025, Nephros' Return on Sales is 0.07%, which was up 200.0% from 0.05% recorded in Q2 2025.
  • In the past 5 years, Nephros' Return on Sales ranged from a high of 0.12% in Q1 2025 and a low of 0.79% during Q3 2022
  • For the 5-year period, Nephros' Return on Sales averaged around 0.13%, with its median value being 0.09% (2024).
  • In the last 5 years, Nephros' Return on Sales crashed by -6500bps in 2022 and then skyrocketed by 7400bps in 2023.
  • Quarter analysis of 5 years shows Nephros' Return on Sales stood at 0.12% in 2021, then skyrocketed by 57bps to 0.05% in 2022, then crashed by -279bps to 0.19% in 2023, then soared by 149bps to 0.09% in 2024, then dropped by -25bps to 0.07% in 2025.
  • Its last three reported values are 0.07% in Q3 2025, 0.05% for Q2 2025, and 0.12% during Q1 2025.